|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, has approved the following:
1. Increase the authorized share capital from Rs. 12 Crores to Rs. 20 Crores subject to approval by members at AGM.
2. Approved the issue of total 50,00,000 (Fifty lacs), equity shares of Rs. 10/- each on preferential basis as per SEBI (issue of Capital and Disclosure Requirements) Regulations 2009, to promoters / their associates / entities other than promoters on preferential basis, subject to approval by members at A.G.M. |
|
|